Modern Prostate Cancer Treatment: Robotic Surgery vs. Traditional Approaches
A comprehensive evidence-based comparison of robotic prostatectomy, open surgery, and radiation therapy for prostate cancer — with outcomes data, recovery timelines, and cost comparisons for GCC patients considering treatment in Hong Kong.
Understanding Your Treatment Options
Prostate cancer is one of the most common cancers among men worldwide, and its incidence in the Gulf region has been rising steadily over the past decade. For men diagnosed with localised prostate cancer, choosing the right treatment approach is one of the most important decisions they will face. This guide provides a comprehensive, evidence-based comparison of the three primary treatment modalities: robotic-assisted surgery, open surgery, and radiation therapy.
The Scale of Prostate Cancer in the GCC
Prostate cancer is the second most common cancer among men in the Gulf Cooperation Council countries. The age-standardised incidence rate has increased by approximately 3–5% annually over the past decade, driven by improved screening, longer life expectancy, and changing dietary patterns [1].
Early detection through PSA (Prostate-Specific Antigen) testing and MRI-guided biopsy has dramatically improved outcomes. When caught at an early stage, prostate cancer has a 5-year survival rate exceeding 98% — making the choice of treatment approach critical for long-term quality of life.
Treatment Comparison at a Glance
| Feature | Robotic Surgery (RARP) | Open Surgery | Radiation Therapy |
|---|---|---|---|
| Hospital Stay | 1–2 days | 5–7 days | Outpatient |
| Blood Loss | 100–200 ml | 500–1500 ml | None |
| Incision Size | 5–6 ports (8–12 mm each) | 15–20 cm | None |
| Return to Work | 2–3 weeks | 6–8 weeks | 1–2 weeks |
| Continence Recovery (12 months) | 90–95% | 70–85% | 80–90% |
| Erectile Function Preservation | 70–85% (nerve-sparing) | 40–60% | 50–70% |
| Cancer Control (10-year BCR-free) | 85–92% | 83–90% | 80–88% |
Robotic-Assisted Radical Prostatectomy (RARP)
How It Works
The surgeon operates through 5–6 small incisions using the da Vinci robotic system, which provides 10x magnification and 360-degree instrument articulation. The prostate gland is removed entirely along with the seminal vesicles, and the bladder is reconnected to the urethra with precise suturing.
Key Advantages
Superior Nerve Preservation: The enhanced 3D visualisation allows surgeons to identify and preserve the neurovascular bundles responsible for erectile function with unprecedented precision. Studies show nerve-sparing rates of 85–90% with robotic surgery compared to 50–70% with open approaches [2].
Minimal Blood Loss: Average blood loss during RARP is 100–200 ml, compared to 500–1500 ml for open surgery. Blood transfusion rates are less than 1% for robotic procedures.
Faster Continence Recovery: Research published in European Urology demonstrates that 93% of RARP patients achieve full urinary continence within 12 months, compared to 78% for open surgery patients [3].
Shorter Recovery: Most patients are discharged within 24–48 hours and return to normal activities within 2–3 weeks.
Who Is a Good Candidate?
RARP is ideal for men with localised prostate cancer (stages T1–T2), PSA levels below 20 ng/ml, and a Gleason score of 6–7. It is also suitable for select high-risk patients when performed by experienced surgeons.
Open Radical Prostatectomy
How It Works
The surgeon makes a single incision (15–20 cm) in the lower abdomen to access and remove the prostate gland. This approach has been performed for over 50 years and remains available at most hospitals worldwide.
When It May Be Preferred
Open surgery may be considered when robotic facilities are unavailable, for very large prostates (over 150 grams), or when extensive lymph node dissection is required. However, in Hong Kong, all major private hospitals now offer robotic surgery as the standard approach.
Limitations
Open surgery is associated with greater blood loss, longer hospital stays, higher rates of wound complications, and slower recovery of continence and erectile function compared to robotic approaches.
Radiation Therapy
External Beam Radiation (EBRT)
Modern intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT) deliver precisely targeted radiation to the prostate over 5–8 weeks (IMRT) or 5 sessions (SBRT). Treatment is non-invasive and performed on an outpatient basis.
Brachytherapy
Radioactive seeds are implanted directly into the prostate gland under ultrasound guidance. This approach delivers a high dose of radiation to the tumour while minimising exposure to surrounding tissues.
Considerations
While radiation therapy avoids surgical risks, it carries its own side effects including radiation cystitis (bladder irritation), radiation proctitis (rectal inflammation), and a gradual decline in erectile function over 2–5 years. Additionally, if cancer recurs after radiation, salvage surgery is technically more challenging.
Why GCC Patients Choose Robotic Surgery in Hong Kong
Hong Kong offers a unique combination of factors that make it the ideal destination for prostate cancer treatment:
- Experienced robotic surgeons with individual caseloads exceeding 500 procedures
- Latest-generation da Vinci Xi systems at all major private hospitals
- JCI-accredited facilities ensuring international safety standards
- Muslim-friendly environment with halal food, prayer facilities, and Arabic-speaking coordinators
- Cost savings of 30–50% compared to equivalent treatment in the US or UK
- Visa-free entry for all GCC nationals
Frequently Asked Questions
What is the success rate of robotic prostatectomy?
Robotic prostatectomy achieves cancer-free rates of 85–92% at 10 years for localised disease. When combined with appropriate patient selection and experienced surgical teams, outcomes are excellent.
Will I be incontinent after surgery?
With modern robotic techniques and experienced surgeons, over 90% of patients recover full urinary continence within 12 months. Early pelvic floor exercises significantly accelerate recovery.
How does radiation compare to surgery for long-term cancer control?
Both approaches achieve similar 10-year cancer control rates for low and intermediate-risk disease. However, surgery provides a definitive pathological specimen that confirms complete cancer removal, while radiation relies on PSA monitoring.
Can I have robotic surgery if my cancer is aggressive?
Yes. Experienced robotic surgeons in Hong Kong routinely perform extended procedures for high-risk prostate cancer, including wide resection margins and extended lymph node dissection.
References
[1] Bray F, et al. "Global cancer statistics 2022." CA: A Cancer Journal for Clinicians. 2024;74(3):229-263.
[2] Ficarra V, et al. "Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies." European Urology. 2009;55(5):1037-1063.
[3] Haglind E, et al. "Urinary incontinence and erectile dysfunction after robotic versus open radical prostatectomy: a prospective, controlled, nonrandomised trial." European Urology. 2015;68(2):216-225.
